The table below shows EyePoint Pharmaceuticals, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$221.04M
$132.93M
$64.66M
$49.64M
$28.50M
$17.42M
SG&A
$51.61M
EYPT annual revenue (10-K history)
EyePoint Pharmaceuticals, Inc. reported annual revenue of $31.37M for fiscal year 2025. That is down 27.5% from $43.27M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.62M (FY 2016) to $31.37M. Figures come from the company's audited annual reports as filed with the SEC.